ARTICLE | Financial News
GlycoDesign files for IPO
October 2, 2000 7:00 AM UTC
GlycoDesign (Toronto, Ontario), which is developing drugs for cancer, inflammatory and infectious diseases, filed for a Canadian IPO that will be underwritten by Loewen, Ondaatje, McCutcheon; BMO Nesb...